CN Patent

CN101220044A — 端粒酶抑制剂及其制备方法和用途

Assigned to China Pharmaceutical University · Expires 2008-07-16 · 18y expired

What this patent protects

本发明涉及药物化学领域，具体涉及一类噻唑[5，4－b]并吡啶类化合物(工)、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为端粒酶抑制剂的用途。

USPTO Abstract

本发明涉及药物化学领域，具体涉及一类噻唑[5，4－b]并吡啶类化合物(工)、它们的制备方法、含有这些化合物的药用组合物以及它们的医疗用途，特别是作为端粒酶抑制剂的用途。

Drugs covered by this patent

imetelstat-sodium (IMETELSTAT SODIUM)

Patent Metadata

Patent number: CN101220044A
Jurisdiction: CN
Classification: —
Expires: 2008-07-16
Drug substance claim: No
Drug product claim: No
Assignee: China Pharmaceutical University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.